Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-03

Clinical Trial Update: OC-01 (Varenicline) Nasal Spray and Dry Eye Signs and Symptoms in Daily Disposable Contact Lens Wearers [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating OC-01 (varenicline) nasal spray for dry eye signs and symptoms in daily disposable contact lens wearers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OC-01 (varenicline nasal spray)

Snippet

Sponsor: Center for Ophthalmic and Vision Research, LLC | Conditions: Dry Eye | Phase 4 | Status: COMPLETED